• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Amarin Announces Proposed Public Offering of American Depositary Shares

    Gabrielle Lakusta
    Jan. 30, 2018 09:19AM PST
    Pharmaceutical Investing

    Amarin (NASDAQ:AMRN) today announced a registered underwritten public offering of its American Depositary Shares. All of the shares in the proposed offering are to be sold by Amarin. As quoted in the press release: The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be …

    Amarin (NASDAQ:AMRN) today announced a registered underwritten public offering of its American Depositary Shares. All of the shares in the proposed offering are to be sold by Amarin.
    As quoted in the press release:

    The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. On January 26, 2018, the last sale price of the ADSs on The NASDAQ Global Market was $4.27 per share.

    Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

    Click here to read the full press release.

    cantor fitzgeraldpharmaceutical investingunderwritten public offeringpublic offeringnasdaq global marketamerican depositary shares
    The Conversation (0)

    Go Deeper

    AI Powered
    Maritime Resources Announces an up to $10 Million Best Efforts Private Placement Financing

    Maritime Resources Announces an up to $10 Million Best Efforts Private Placement Financing

    iShares U.S. Pharmaceuticals ETF

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×